Literature DB >> 7785962

Renal function in the elderly.

M M Lubran1.   

Abstract

Renal size and volume decrease with age, accompanied by intrarenal vascular changes. The number of glomeruli decreases and the mass of the juxtamedullary nephrons falls. The result is a decrease in the filtration area of the glomerular basement membrane and decreased permeability. The glomerular filtration rate (GFR) is reduced with aging. The GFR is approximated by the endogenous creatinine clearance, which falls in parallel with the inulin clearance (the true measure of GFR) and is always greater because of tubular excretion of creatinine. Analytical methods for serum and urine creatinine overestimate its concentration and suffer, to varying degrees, from interferences, making the normal range method dependent. A further uncertainty arises from the use of a correction to standard surface area. Serum creatinine concentration is an insensitive indicator of renal function in the elderly. Deduction of creatinine clearance from serum creatinine concentration, weight and age using one of many formulae gives only approximate values, usually too high, and is unsuitable for debilitated and seriously ill patients. Tubular function, in general, is decreased in the elderly. The ability of the kidney to concentrate urine maximally after water deprivation decreases with age, as does the ability to excrete a water and salt load, particularly during the night. Nocturnal polyuria is common in the elderly. The aged kidney can maintain acid-base balance under normal conditions, but not when subjected to an acid load.

Entities:  

Mesh:

Year:  1995        PMID: 7785962

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  9 in total

1.  A population pharmacokinetic model for cefuroxime using cystatin C as a marker of renal function.

Authors:  Anders Viberg; Anders Lannergård; Anders Larsson; Otto Cars; Mats O Karlsson; Marie Sandström
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

2.  Decreases in urine specific gravity and urinary creatinine in elderly women.

Authors:  J Moriguchi; T Ezaki; T Tsukahara; Y Fukui; H Ukai; S Okamoto; S Shimbo; H Sakurai; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  2005-06-14       Impact factor: 3.015

Review 3.  The safety and tolerability of donepezil in patients with Alzheimer's disease.

Authors:  Stephen Jackson; Richard J Ham; David Wilkinson
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

Review 4.  Dietary electrolytes and hypertension in the elderly.

Authors:  T Rosenthal; A Shamiss; E Holtzman
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

5.  The negative effect of unloading exceeds the bone-sparing effect of alkaline supplementation: a bed rest study.

Authors:  P Frings-Meuthen; G Bernhardt; J Buehlmeier; N Baecker; F May; M Heer
Journal:  Osteoporos Int       Date:  2018-09-25       Impact factor: 4.507

6.  A rare case of acute renal failure secondary to rhabdomyolysis probably induced by donepezil.

Authors:  Osman Zikrullah Sahin; Teslime Ayaz; Suleyman Yuce; Fatih Sumer; Serap Baydur Sahin
Journal:  Case Rep Nephrol       Date:  2014-04-27

7.  Age as a Risk Factor in the Occurrence of Complications during or after Bronchoscopic Lung Biopsy.

Authors:  Irina Pocienė; Rasa Gauronskaitė; Domantas Galkauskas; Antanas Mainelis; Vygantas Gruslys; Edvardas Danila
Journal:  Geriatrics (Basel)       Date:  2022-03-21

Review 8.  The treatment of metastatic non-small cell lung cancer in the elderly: an evidence-based approach.

Authors:  David E Dawe; Peter Michael Ellis
Journal:  Front Oncol       Date:  2014-07-10       Impact factor: 6.244

9.  A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance.

Authors:  Nor Asyikin Mohd Tahir; Shamin Mohd Saffian; Farida Hanim Islahudin; Abdul Halim Abdul Gafor; Mohd Makmor-Bakry
Journal:  J Korean Med Sci       Date:  2020-09-21       Impact factor: 2.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.